Team

Šarūnas was previously a partner in OAKLINS member M&A Baltics (2014 – 2018), and before that partner in GILD Corporate Finance and GILD Bankers (2005 – 2014). In 1999, Šarūnas was was one of the three partners in the management buyout of Hermis Finansai from Hermis Bank, by then majority-owned by SEB, where he worked in the corporate finance department, having transferred from equity research in 1998.

Through over two decades of experience as an investment banker, Šarūnas executed a number of capital raising, trade sale and acquisition transactions. His notable transactions include the sale of a strategic minority stake in AB Novaturas to Neset Kockar, sale of medDream to a porfolio company of Bregal Unternehmerkapital, acquisition of Niedomice tissue paper plant by Grigeo, Sale of VIC Klinika to InMedica, sale of a 25% stake in Light Conversion to 7-Industries, sale of Ecoservice to Eco Baltia, acquisition of MediCa klinika, Kardiolita, Bendrosios medicinos praktika and Svalbono klinika by Repharm, sale of Danpower Baltic to Idex, acquisition of Emperia Holding S.A. by Maxima Group, sale Viltechmeda to Moog, Inc, IPO of Agrowill (now Auga Group), private placement and listing on First North alternative market of K2 LT as well as raising equity and debt financing from EBRD for E-Energija. He was instrumental in establishing the corporate bond market in Lithuania in 1999-2005, with over 15 transactions for a range of issuers ranging from Lithuanian gas and power utilities to private banks and industrial and energy companies, such as Malsena and E-Energija. He advised on the project financing, including both equity and debt, for what was then the first large scale wind farm project by Vėjų Spektras in Lithuania in 2005, and advised on the sale of the same park to Inter RAO Lietuva.